The Pandemic Hurt, But EY Expects More Biopharma Deal-Making In 2021

Life Sciences M&A Was Almost Half Of 2019’s Record

 
• By Joseph Haas
  
fire embers
Biopharma companies have ample deal-making "firepower" to deploy in 2021
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business